期刊文献+

来氟米特治疗银屑病关节炎11例疗效观察 被引量:1

下载PDF
导出
出处 《山东医药》 CAS 北大核心 2005年第4期22-22,共1页 Shandong Medical Journal
  • 相关文献

同被引文献8

  • 1Nousari HC,Anhalt GJ.Bullous pemphigoid treated with leflunomide:a novel immunomodulatory agent.Arch Dermatol,2000;136 (10):1204
  • 2Hamilton LC,Vojnovic I,Warner TD.A771726,the activemetabolite of leflunomide,drectly inhibits the activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner.Br J Pharmacol,1999;127(7):1589
  • 3Alldred A,Emery P.Leflunomide:a novel D MARD for the treatment of rheumatoid arthritis.Expert Opin Pharmacother,2001;2 (1):125
  • 4Jankovic V,Samardzic T,Stosic Grujicic S,et al.Cell-specific inhibition of inducible nitric oxide synthase activation by leflunomide.Cell Immunol,2000;199(2):73
  • 5Kraan MC,de Koster BM,Elferink JG,et al.Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheumatoid arthritis:findings in a prospective,randomized,double-blind clinical trial in fifteen patients.Arthritis Rheum,2000;43(7):1488
  • 6Herrmann ML,Schleyerbach R,Kirschbaum BJ.Leflunomide:an immun-omodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases.Immunophar macology,2000;47(2~3):273
  • 7Mizushima Y,Amano Y,Kitagawa H,et al.Oral administration of leflunomide (H WA486)results in prominent suppression of immunoglobulin E formation in a rat type 1 allergy model.J Pharmacol Exp Ther,1999;288(2):849
  • 8Xiao F,Lv SF,Xu SY,et al.Leflunomide a new disease-modifying drugs for treating active rheumatoid arthritis in Phase Ⅱ methotrexatecontrolled clinical trial.Chinese Medcine,2001;in press.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部